Literature DB >> 10764131

Trends in late-stage breast, cervical and colorectal cancers in blacks and whites.

A P Polednak1.   

Abstract

OBJECTIVE: This study examined the black-white disparities in diagnosis of late-stage breast, cervical, and colorectal cancers, which could change over time, especially in view of changes in the health-care system.
METHODS: Recent trends (1988-95) in stage distribution were examined by age group (<65 and 65+ years) for the geographic areas covered by the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) Program.
RESULTS: Proportions of breast and cervical (but not colorectal) cancers that were late-stage declined in both races and black-white disparities had narrowed by 1995, especially for patients diagnosed at age 65 years or older. The proportion of breast and cervical cancers that were late stage declined for blacks in counties with a black poverty rate of 20% or higher.
CONCLUSIONS: Some progress toward black-white equity in stage at diagnosis was evident, consistent with reported trends in use of screening tests, but further surveillance and research are needed.

Entities:  

Mesh:

Year:  2000        PMID: 10764131

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  3 in total

1.  Telephone outreach to increase colorectal cancer screening in an urban minority population.

Authors:  Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

2.  Contrasts in rural and urban barriers to colorectal cancer screening.

Authors:  Terry C Davis; Alfred Rademaker; Stacy Cooper Bailey; Daci Platt; Julie Esparza; Michael S Wolf; Connie L Arnold
Journal:  Am J Health Behav       Date:  2013-05

3.  Disparities in preventive procedures: comparisons of self-report and Medicare claims data.

Authors:  Kevin Fiscella; Kathleen Holt; Sean Meldrum; Peter Franks
Journal:  BMC Health Serv Res       Date:  2006-09-29       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.